Integrity of randomized clinical trials : (Record no. 43801)

MARC details
001 - CONTROL NUMBER
control field 23858635
003 - CONTROL NUMBER IDENTIFIER
control field 0000
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20251015143625.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 240906s2025 flu b 000 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2024041985
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781032601229
035 ## - SYSTEM CONTROL NUMBER
System control number 23858635
040 ## - CATALOGING SOURCE
Original cataloging agency DNLM/DLC
Language of cataloging eng
Description conventions rda
Transcribing agency DLC
Modifying agency DLC
042 ## - AUTHENTICATION CODE
Authentication code pcc
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number R 853 .H8
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number W 20.55.C5
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 174.2/8
Edition number 23/eng/20241209
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Khan Khalid
245 10 - TITLE STATEMENT
Title Integrity of randomized clinical trials :
Remainder of title how to prevent research misconduct and ensure transparency /
250 ## - EDITION STATEMENT
Edition statement First edition.
263 ## - PROJECTED PUBLICATION DATE
Projected publication date 2502
264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Boca Raton :
Name of publisher, distributor, etc CRC Press,
Date of publication, distribution, etc 2025.
300 ## - PHYSICAL DESCRIPTION
Extent xiii, 198p.
Other physical details ill.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term unmediated
Media type code n
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term volume
Carrier type code nc
Source rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Randomized clinical trials -- Integrity of trials -- Ethics committee approval and participant consent -- Trial planning -- Trial oversight -- Publishing trials responsibly -- Authorship of trials -- Evidence syntheses of randomized clinical trials -- Investigating research misconduct allegations.
520 ## - SUMMARY, ETC.
Summary, etc "Today scientists are expected to be more accountable and transparent than at any time in history. Globally the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefit from the innovative contributions made by researchers. It is therefore more important than ever that ethics, transparency and professionalism explicitly guide research integrity. Despite the clear importance of acquiring a fundamental understanding of clinical trials in the context of health research and innovation, medical training generally fails to cover clinical trial integrity in its curriculum, including it neither at undergraduate nor at postgraduate levels. This new book provides a curriculum to address this gap, offering best practice guidelines to improve the quality, openness and trustworthiness of clinical trials and filling a current void in the market. Key Features: The first book on clinical trial integrity. Provides clear guidance on how to ensure probity in peer review, appraisal of trials and investigation of complaints concerning misconduct in clinical trials. Trains and supports researchers globally in how to undertake trials with integrity. Ensures the increasing demand for public documentation of all aspects throughout the lifecycle of a clinical trial can be met. The book is essential reading for master and doctoral students undertaking courses in clinical trials, epidemiology and medical statistics and an invaluable reference for medical journal editors and peer reviewers, clinicians who recruit patients into trials, pharmaceutical industry professionals, patient and public representatives who engage in clinical trials, systematic reviewers, guideline writers, funders and regulators of clinical trials"--
Assigning source Provided by publisher.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Randomized Controlled Trials as Topic
General subdivision ethics
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Online version:
Main entry heading Khan, Khalid Saeed.
Title Integrity of randomized clinical trials
Edition First edition.
Place, publisher, and date of publication Boca Raton : CRC Press, 2025
International Standard Book Number 9781003461401
Record control number (DLC) 2024041986
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
a 7
b cbc
c orignew
d 1
e ecip
f 20
g y-gencatlg
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type Books
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Permanent Location Current Location Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
    Library of Congress Classification     NILE UNIVERSITY OF NIGERIA - MAIN LIBRARY NILE UNIVERSITY OF NIGERIA - MAIN LIBRARY 10/15/2025   R 853 k43 2025 0199246 10/15/2025 10/15/2025 Books
    Library of Congress Classification     NILE UNIVERSITY OF NIGERIA - MAIN LIBRARY NILE UNIVERSITY OF NIGERIA - MAIN LIBRARY 10/16/2025   R8 53 K43 2025 0199245 10/16/2025 10/16/2025 Books